Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Holding TSE:CRDL?
Track your performance easily
CRDL Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.91 - C$4.26
Previous CloseC$2.68
Volume133.47K
Average Volume (3M)157.82K
Market Cap
C$184.92M
Enterprise ValueC$150.16M
Total Cash (Recent Filing)C$34.93M
Total Debt (Recent Filing)C$174.34K
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Nov 12, 2024EPS Estimate
-C$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding69,881,720
10 Day Avg. Volume96,495
30 Day Avg. Volume157,817
Standard Deviation0.22
R-Squared0.02
Alpha0.00986
Financial Highlights & Ratios
Price to Book (P/B)6.79
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.51Price Target Upside366.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Cardiol Therapeutics News
PremiumCompany Announcements
Cardiol Therapeutics Inc.: Financial Update
PremiumCompany Announcements
Cardiol Therapeutics Gains Key Legal Consent
PremiumCompany Announcements
Cardiol Therapeutics Shareholders Approve Resolutions
PremiumCompany Announcements
Cardiol Therapeutics Advances Heart Disease Treatments
Options Prices
Currently, No data available
---
Ownership Overview
6.55% Insiders
0.08% Mutual Funds
9.37% Other Institutional Investors
84.01% Public Companies and
Individual Investors
CRDL FAQ
What was Cardiol Therapeutics’s price range in the past 12 months?
Cardiol Therapeutics lowest stock price was C$0.91 and its highest was C$4.26 in the past 12 months.
What is Cardiol Therapeutics’s market cap?
Currently, no data Available
When is Cardiol Therapeutics’s upcoming earnings report date?
Cardiol Therapeutics’s upcoming earnings report date is Nov 12, 2024 which is in 80 days.
How were Cardiol Therapeutics’s earnings last quarter?
Cardiol Therapeutics released its earnings results on Aug 12, 2024. The company reported -C$0.1 earnings per share for the quarter, beating the consensus estimate of -C$0.141 by C$0.041.
Is Cardiol Therapeutics overvalued?
According to Wall Street analysts Cardiol Therapeutics’s price is currently Undervalued.
Does Cardiol Therapeutics pay dividends?
Cardiol Therapeutics does not currently pay dividends.
What is Cardiol Therapeutics’s EPS estimate?
Cardiol Therapeutics’s EPS estimate is -C$0.14.
How many shares outstanding does Cardiol Therapeutics have?
Cardiol Therapeutics has 68,998,314 shares outstanding.
What happened to Cardiol Therapeutics’s price movement after its last earnings report?
Cardiol Therapeutics reported an EPS of -C$0.1 in its last earnings report, beating expectations of -C$0.141. Following the earnings report the stock price went up 3.61%.
Which hedge fund is a major shareholder of Cardiol Therapeutics?
Currently, no hedge funds are holding shares in TSE:CRDL
---
Cardiol Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$12.51 (366.83% Upside)
C$12.51 (366.83% Upside)
Blogger Sentiment
Bullish
TSE:CRDL Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $102.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
99.01%
12-Months-Change
Fundamentals
Return on Equity
-106.90%
Trailing 12-Months
Asset Growth
-46.06%
Trailing 12-Months
Company Description
Cardiol Therapeutics
Cardiol Therapeutics, Inc. is a biotechnology company, which engages in the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for inflammatory diseases. Its products pipelines include heart failure products, glioblastoma multiforme and pharmaceutical cannabidol. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.
---
CRDL Stock 12 Month Forecast
Average Price Target
C$12.51
▲(366.83% Upside)
Technical Analysis
Cardiol Therapeutics
―
Aclaris Therapeutics
―
Soligenix
―
Adverum Biotechnologies
―
Fate Therapeutics
―
Best Analysts Covering CRDL
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+49.58%
reiterated a buy rating 11 months ago
Copying Douglas Loe's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +49.58% per trade.
---